Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

New Microbiologica

Volumn 34, Issue 3, 2011, Pages 291-298

  Vojtová, Vladimíra ^a   Kolář, Milan ^a   Hricová, Kristýna ^a   Uvízl, Radek ^a   Neiser, Jan ^a   Blahut, Ladislav ^a   Urbánek, Karel ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Antibiotics; Pseudomonas aeruginosa; Resistance; Utilization

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; DRUG DERIVATIVE; GENTAMICIN; PENICILLANIC ACID; PIPERACILLIN; SULBACTAM; TAZOBACTAM;

ARTICLE; CZECH REPUBLIC; DRUG EFFECT; INTENSIVE CARE UNIT; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA;

AMIKACIN; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; CZECH REPUBLIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENTAMICINS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; SULBACTAM;

PSEUDOMONAS AERUGINOSA;

EID: 84860388809     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Allegranzi B., Luzzati R., Luzzani A., et al. (2002). Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit- acquired infections. J. Hosp. Infect. 52, 136-140. (Pubitemid 38001944)
2. Aloush V., Navon-Venezia S., Seigman-Igra Y., et al. (2006). Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother. 50, 43-48. (Pubitemid 43042900)
3. AnatomiCAL therapeutic chemical (ATC) index (including defined daily doses (DDDs) for plain substances). WHO collaboration centre for drugs statistics methodology, Oslo, 2009.
4. Archibald L., Phillips L., Monnet D., et al. (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin. Infect. Dis. 24, 211-215. (Pubitemid 27081545)
5. Carmeli Y., Troillet N., Eliopoulos G.M., Samore M.H. (1999). Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother. 43, 1379-1382. (Pubitemid 29259329)
6. Clinical and Laboratory Standards Institute. (2009). Performance standards for antimicrobial susceptibility testing, nineteenth informational supplement. 29, M100-S19.
7. Falagas M.E., Kopterides P. (2006). Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J. Hosp. Infect. 64, 7-15. (Pubitemid 44161380)
8. Flamm R.K., Weaver M.K., Thornsberry C., et al. (2004). Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob. Agents Chemother. 48, 2431-1436.
9. Gaynes R. (1997). The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect. Dis. Clin. North Am. 11, 757- 765. (Pubitemid 28033738)
10. Gaynes R., Edwards J.R. (2005) National nosocomial infections surveillance system. Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis. 41, 848-854. (Pubitemid 41266753)
11. Hsueh P.R., Chen W.H., Luh K.T. (2005). Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing noso-comial infections from 1991-2003 at a university hospital in Taiwan. Int. J. Antimicrob. Agents. 26, 463-472.
12. Johnson J.K., Smith G., Lee M.S. et al. (2009). The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. J. Infect. Dis. 200, 900-905.
13. Koláč M., Urbánek K., Látal T. (2001). Antibiotic selection pressure and development of bacterial resistance. Int. J. Antimicrob. Agents. 17, 357-363. (Pubitemid 32401534)
14. Loeffler J.M., Garbino J., Lew D. et al. (2003). Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand. J. Infect. Dis. 35, 843-850. (Pubitemid 38028921)
15. Neu H.C. (1992). The crisis in antibiotic resistance. Science. 257, 1064-1073.
16. Shorr A.F. (2009). Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit. Care Med. 37, 1463- 1469.
17. Urbánek K., KoláŘM., LoveČkovÁ Y. et al. (2007). Influence of 3rd generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J. Clin. Pharm. Ther. 32, 403- 408. (Pubitemid 47063165)
18. Zavascki A.P., Barth A.L., Goldani L.Z. (2008). Nosocomial bloodstream infections due to metallo- β-lactamase-producing Pseudomonas aeruginosa. J. Antimicrob. Chemother. 61, 1183-1185. (Pubitemid 351524470)
19. Zavascki A.P. Barth A.L., Goncalves A.L.S., et al. (2006). The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J. Antimicrob. Chemother. 58, 387-392. (Pubitemid 44294952)